Resources
Compliance to the IVDR will be a major effort for the diagnostic laboratories
The BioMed Alliance Taskforce on IVD, in collaboration with the European Haematology Association and the European Federation of Clinical Chemistry and Laboratory Medicine, conducted a survey on the cu...
Reducing Bureaucracy in Clinical Trials: the Coalition Recommendations are out!
The Coalition on Reducing Bureaucracy in Clinical Trials, in which BioMed Alliance is an active member, just published a series of concrete and consensus-based recommendations for reducing administrat...
New BioMed Alliance Statement on HERA: Will new agency live up to citizens’ expectations?
The European Commission has recently published its Communication on the new Health Emergency Response Authority (HERA) which is supposed to be established within the Commission and start operations ea...
Facilitating patient involvement in Continuing Medical Education
The BioMed Alliance CME Experts Committee facilitates cooperation between medical societies and works on enhancing the quality of CME. Together with the European Patients Forum (EPF), the committee ha...
BioMed Alliance response to the public consultation on the European Health Data Space
BioMed Alliance submitted a response to the public consultation on the European Health Data Space (EHDS) launched by the European Commission, with the help and input of our new Taskforce on Health Dat...
Statement delay MDR Application Date
The BioMed Alliance published a statement on 9 April welcoming the European Commission’s proposal to postpone the application date of the Medical Devices Regulation (MDR) by one year, to 26 May 20...
Implementation of the IVDR: a ticking time bomb for the diagnostic sector?
Laboratory experts from the BioMed Alliance IVD Working Group released a new statement highlighting a looming threat for the diagnostic sector: the slow implementation of the new In Vitro Diagnostic R...
Statement calling for urgent actions to prevent a collapse of the diagnostic sector
In May 2021, the BioMed Alliance published a new statement highlighting a looming threat for the diagnostic sector: the slow implementation of the new In Vitro Diagnostic Regulation (IVDR), a ticking...
BioMed Alliance joins the call for an extended mandate of the European Centre for Disease Prevention and Control
The BioMed Alliance joined the European Chronic Disease Alliance (ECDA) and 9 other European health organisations in a joint letter addressed to the Council of the European Union to call for an extend...
BioMed Alliance welcomes HERA inception impact assessment.
The BioMed Alliance has prepared a response to the consultation on the inception impact assessment for the new Health Emergency Response Authority (HERA) with its Board of Directors.
HERA is suppos...
The BioMed Alliance selected as a stakeholder in the TEHDAS Joint Action
The Joint Action Towards the European Health Data Space (TEHDAS) is a European project coordinated by the Finnish Innovation Fund SITRA and led by the Member States to develop joint European principle...
Biomedical Alliance views on the European Health Data Space
Early January the European Commission launched a consultation on the inception impact assessment for the new regulation for the European Health Data Space (EHDS) that is scheduled to be adopted du...